December 4, 2018
In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs.
March 13, 2023
UC San Diego researchers have identified a strong association between the product of a gene expressed in most cancers and elevated levels of white blood cells that produce antibodies within tumors, suggesting a new therapeutic target.
September 23, 2020
Five Jacobs School of Engineering graduate students conducting pioneering biomedical research have been named Siebel Scholars.
March 23, 2023
Ten UC San Diego postdoctoral scholars are applying artificial intelligence (AI) methods to their research in a range of fields thanks to support from the Eric and Wendy Schmidt AI in Science Postdoctoral Fellowship, a program of Schmidt Futures.
December 6, 2011
…advancing and fulfilling the therapeutic promise of stem cells. The consortium opened its doors with a ribbon-cutting ceremony involving dozens of local officials, scientists, and patient advocates. But more than just a celebration of the opening of a building, the event exalted the driving idea behind it: Stem cell researchers…
October 23, 2014
…improved ways to deliver therapeutic drugs inside cells, agreed to help. Funding from NIAID arrived within days. Over the next few years, he and colleagues created multiple analogs or variations of cidofovir. The first was brincidofovir. In cultured cell tests, the compound proved active against an array of viruses, blocking…
February 16, 2017
…origami in fields like therapeutics and bioelectronics. We’re applying it to targeted drug delivery,” said Raina Borum, a fourth year nanoengineering major and the team lead for the project. The team chose to design a “sleeve”—think Christmas stocking—to carry the hidden cargo. But the shape isn’t what makes the design…
September 22, 2022
With a $126 million grant from the National Institutes of Health, a multi-institution team of researchers at UC San Diego, Salk Institute and elsewhere has launched a new Center for Multiomic Human Brain Cell Atlas to describe human brain cells in unprecedented detail over a lifetime.
February 15, 2023
“The pandemic highlighted an underserved area—rapid detection of various different pathogens such as COVID, the flu, and other viruses,” says Shane Bowen ‘00, ‘05, a co-founder of Palamedrix.
January 31, 2023
The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
